BioReliance
 
Home About Us Services What's Your Product? Resources Careers Contact Us
  Home
 

News

Darryl L. Goss joins Bioreliance Darryl L. Goss has been appointed Vice President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly formed Business Unit.
Click here to read the press release.

 

   

The use of animal models to determine the toxicity of a pharmaceutical, biopharmaceutical or medical device is a required part of evaluating the overall safety of the product and predicting its effects on humans.

Traditional Toxicology Studies

Back to Mammalian Toxicology

Single-dose, 14-day or 28-day repeated-dose and 90-day subchronic studies are currently performed at BioReliance. Full analytical chemistry support is available for dose formulation, homogeneity, stability and dose analysis. BioReliance also conducts ISO biocompatibility testing of medical device materials.

Assays offered by BioReliance:

  • Studies for Repeated-Dose Studies
  • Analytical Chemistry Services

Studies for Repeated-Dose Studies

Assay Description Protocol
28-Day Repeated-Dose Oral Toxicity Study 2G11
21-Day Repeated-Dose Dermal Toxicity 2D13
28-Day Repeated-Dose Dermal Toxicity Study 2D11
13-Week Subchronic Oral Toxicity Study 7G31 or 7G32
13-Week Subchronic Dosed Feed Toxicity Study 7F31 or 7F32

Analytical Chemistry Services

Method Validation using HPLC or GC methodology

  • Formulation verification
  • Stability, homogeneity and purity determinations
  • Sample Retention/Storage Services
 
for further information and enquiries please contact: info@bioreliance.com